These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11503532)

  • 61. Hormone replacement therapy and vaginal bleeds. Theoretical aspects and clinical management.
    Samsioe G
    Zentralbl Gynakol; 1996; 118(4):181-7. PubMed ID: 8651004
    [No Abstract]   [Full Text] [Related]  

  • 62. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Hypertension in postmenopausal women --selected pathomechanisms].
    Pośnik-Urbańska A; Kawecka-Jaszcz K
    Przegl Lek; 2006; 63(12):1313-7. PubMed ID: 17642147
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The confidence that women have in a gynecologist....].
    Fernández del Castillo C
    Ginecol Obstet Mex; 2002 Aug; 70():371. PubMed ID: 12448039
    [No Abstract]   [Full Text] [Related]  

  • 66. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.
    Kalantaridou SN; Naka KK; Bechlioulis A; Makrigiannakis A; Michalis L; Chrousos GP
    Trends Endocrinol Metab; 2006 Apr; 17(3):101-9. PubMed ID: 16515863
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Plasma concentrations of levonorgestrel in patients with an intrauterine progestogen delivery system: do they have any significance?
    Trinh XB; van Dam PA; Tjalma WA
    Maturitas; 2006 Aug; 55(1):94-5; author reply 96-7. PubMed ID: 16675171
    [No Abstract]   [Full Text] [Related]  

  • 68. Progesterone, progestins, pregnancy and breast cancer risk.
    Ferretti G
    Breast Cancer Res Treat; 2007 Jul; 103(3):373-4. PubMed ID: 17063269
    [No Abstract]   [Full Text] [Related]  

  • 69. Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.
    Derry PS
    Womens Health Issues; 2004; 14(6):212-9. PubMed ID: 15589771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
    Kovacev-Zavisić B; Icin T; Kovacev N
    Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence.
    Harman SM; Naftolin F; Brinton EA; Judelson DR
    Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism.
    Palacios S; Foidart JM; Genazzani AR
    Maturitas; 2006 Nov; 55(4):297-307. PubMed ID: 16949774
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view.
    Speroff L
    Maturitas; 2004 Sep; 49(1):51-7. PubMed ID: 15351096
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The role of endocrine therapy in ovarian cancer].
    Emons G; Ortmann O; Schulz KD
    Gynakologe; 1993 Apr; 26(2):123-30. PubMed ID: 8508981
    [No Abstract]   [Full Text] [Related]  

  • 76. Hormone replacement therapy and high blood pressure.
    Jespersen CM
    Am J Hypertens; 1997 Mar; 10(3):366-7. PubMed ID: 9056697
    [No Abstract]   [Full Text] [Related]  

  • 77. Post-menopausal oestrogen-progestogen therapy.
    IARC Monogr Eval Carcinog Risks Hum; 1999; 72():531-628. PubMed ID: 10533180
    [No Abstract]   [Full Text] [Related]  

  • 78. [Hypertension in postmenopausal women].
    Sidorenko BA; Ugriumova MO
    Kardiologiia; 2003; 43(4):88-95. PubMed ID: 12968610
    [No Abstract]   [Full Text] [Related]  

  • 79. Summaries for patients. Hormone treatment beginning near the onset of menopause.
    Ann Intern Med; 2014 Aug; 161(4):I-19. PubMed ID: 25069612
    [No Abstract]   [Full Text] [Related]  

  • 80. [Gestagens have become of great clinical value. Disadvantages are irregular bleeding and bad temper].
    Landgren BM
    Lakartidningen; 1999 Mar; 96(13):1578-81. PubMed ID: 10218339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.